FindTrial
Sign In

Role of T regulatory cells in leprosy reactions.

Study of T regulatory cells in Type 1 and Type 2 Leprosy Reactions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/03/041273
Enrollment
30
Registered
2022-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A309- Leprosy, unspecified

Interventions

None listed

Sponsors

RML HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult Patients 2. Type 1/ Type 2 reaction 3. Clinically diagnosed 4. Not on treatment for reactions 5. Patients willing to participate

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Autoimmune diseases 3. Infectious comorbidities 4. Use of immunosuppressive drugs for other causes than leprosy

Design outcomes

Primary

MeasureTime frame
Evaluation for assessment of reaction. NFI Motor function Severity scoring Steroid side effectsTimepoint: 4 weeks 8 weeks 12 weeks 16 weeks 20 weeks—

Secondary

MeasureTime frame
THERAPEUTIC IMPLICATION ON T REG CELLS IN REACTIONTimepoint: 5 MONTHS—

Countries

India

Contacts

Public ContactKumari Ritu

Dr. RML HOSPITAL

article.sardana@gmail.com011-23404380

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026